Bruno P. Granwehr, MD, MS, FACP, FIDSA, CMQ
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
About Dr. Bruno P. Granwehr
My focus is on clinical infectious diseases and education. This has recently included formal training as a Facilitator for the REDE to Communicate program in August 2022, now teaching relationship-centered communication to peers. I have also received training in professionalism, in the Vanderbilt University "Promoting Professionalism Course" on December 18-19, 2023, which complements the patient-focused communication program with training addressing peer-peer and peer-patient interactions.
Present Title & Affiliation
Primary Appointment
Professor, Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2005 | The University of Texas Medical Branch, Galveston, Texas, US, M.S. in Clinical Investigation |
| 1999 | University of Iowa Carver College of Medicine, Iowa City, Iowa, US, MD |
| 1994 | University of Iowa College of Liberal Arts, Iowa City, Iowa, US, BS in Microbiology |
Postgraduate Training
| 2025-2025 | Oncology Ethics Certificate Program, Center for Clinical Ethics, University of Texas MD Anderson Cancer Center |
| 2002-2005 | Clinical Fellowship, Infectious Diseases (Internal Medicine), The University of Texas Medical Branch, Galveston, Texas |
| 1999-2002 | Clinical Residency, Internal Medicine, University of Rochester-Strong Memorial Hospital, Rochester, New York |
Licenses & Certifications
| 2014 | American Board of Medical Quality, Certified in Medical Quality |
| 2005 | American Board of Internal Medicine, Diplomat in Infectious Diseases |
| 2005 | Texas Medical License |
| 2002 | American Board of Internal Medicine, Diplomat in Internal Medicine |
Experience & Service
Faculty Academic Appointments
Associate Professor, Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2013 - 2019
Assistant Professor, Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2007 - 2013
Assistant Professor, Internal Medicine, The University of Texas Medical Branch, Galveston, Texas, 2005 - 2006
Administrative Appointments/Responsibilities
Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Vice Chair, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - 2025
Clinical Director, Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - Present
Extramural Institutional Committee Activities
Chair, Acute and Critical Care Advisory Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Utilization Review Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Vice Chair, Acute and Critical Care Subcommittee, The University of Texas MD Anderson Cancer Center, 2022 - 2025
Member, Beaker Steering Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Member, Professional Education Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Transparency Governance Council, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Professional Liability Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2021
Member, Focused Professional Practice Evaluation (FPPE) Oversight Review Group, The University of Texas MD Anderson Cancer Center, 2017 - 2019
Member, Acute and Critical Care Subcommittee, The University of Texas MD Anderson Cancer Center, 2017 - 2022
Member, Psychosocial, Behavioral and Health Services Research Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2019
Member, Credentials Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2016 - 2019
Member, Ambulatory Informatics Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2018
Member, OneConnect (EHR) Super User, Infectious Diseases, The University of Texas MD Anderson Cancer Center, 2015 - Present
Chair, GME Clinical Learning Environment (CLE) Subcommittee, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Member, GME Faculty Development Subcommittee, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Member, GME Transitions of Care IPASS Steering Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Member, Electronic Health Record Provider Officer, Infectious Diseases, MDACC, The University of Texas MD Anderson Cancer Center, 2014 - Present
Member, Sepsis Guidelines Committee, MDACC, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Electronic Health Record Champion, MDACC, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Graduate Medical Education (GME) Committee, MDACC, The University of Texas MD Anderson Cancer Center, 2012 - 2017
Member, GME Budget Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - 2016
Member, Sepsis Collaborative, MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2010 - Present
Member, H1N1 Influenza Task Force, The University of Texas MD Anderson Cancer Center, 2009 - 2012
Member, Clinical Research Committee 3, UT MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2008 - 2010
Member, Infection Control Committee, UT MD Anderson, The University of Texas MD Anderson Cancer Center, 2007 - 2016
Member, Infection Control Committee, St Alphonsus Regional Medical Center, Boise, Idaho, The University of Texas MD Anderson Cancer Center, 2006 - 2007
Member, Baldridge Quality Award (Texas) Application Team, UTMB, The University of Texas MD Anderson Cancer Center, 2006 - 2007
Member, Task Force Immunization for the Elderly, UTMB, The University of Texas MD Anderson Cancer Center, 2005 - 2006
Honors & Awards
| 2025 - 2026 | McGovern Center-Inprint Writing Fellowship, University of Texas McGovern Medical School Center for Humanities and Ethics |
| 2025 | Baylor ID Fellows MD Anderson Faculty Teacher of the Year |
| 2023 - 2026 | Multiyear Appointment Award, University of Texas MD Anderson Cancer Center |
| 2021 | Fellow, Infectious Diseases Society of America |
| 2019 - 2022 | Multiyear Appointment Award, University of Texas MD Anderson Cancer Center |
| 2018 | Baylor ID Fellows MD Anderson Faculty Teacher of the Year |
| 2013 - 2016 | Multiyear Appointment Award, University of Texas MD Anderson Cancer Center |
| 2013 | Doximity Fellowship |
| 2011 - 2020 | Annals of Internal Medicine Top Grade Reviewer, Annals of Internal Medicine |
| 2011 | Fellow, American College of Physicians |
| 2009 | Annals of Internal Medicine Top 10% Reviewer |
| 2008 | Certificate of Appreciation, Volunteer Participation, American College of Physicians |
| 2007 | Annals of Internal Medicine Top 30% Reviewer |
| 2005 | Travel Grant, Infectious Diseases Society of America |
| 2005 | Graduate School of Biomedical Sciences Associates Christina Fleishmann Travel Award, UTMB-Galveston |
| 2004 | Robert Wood Johnson Clinical Scholars Program (accepted) |
| 2003 - 2005 | Herzog Educational Enrichment Award, Graduate School of Biomedical Sciences, UTMB-Galveston |
| 2003 - 2004 | Hospital Academic Fellowship, UTMB-Galveston |
| 2003 | Travel Grant, Infectious Diseases Society of America 41st Annual Meeting of IDSA |
| 2002 - 2003 | T32 NIH-NIAID-Sponsored Postdoctoral Fellowship in Emerging and Reemerging Infectious Diseases, UTMB-Galveston |
| 2002 | American Medical Association: Physicians' Recognition Award |
| 1999 | Healthcare Foundation of New Jersey Humanism in Medicine Award, University of Iowa College of Medicine |
| 1999 | Poster Finalist, Certificate of Merit, Clinical Vignette Competition at the 80th Annual Session of the ACP-ASIM, American College of Physicians-American Society of Internal Medicine |
| 1998 | Barry Freeman Fellowship/Iowa Medical Society Education Fund, University of Iowa Carver College of Medicine |
| 1996 | Society for Pediatric Research/American Pediatric Society Medical Student Fellowship, Children's Hospital-Boston |
| 1994 - 1995 | American Heart Association Medical Student Research Fellowship Program, University of Iowa Carver College of Medicine |
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2015. Current State of HIV Testing in a Comprehensive Cancer Center. Conference. 2015 National Summit on HIV Diagnosis, Prevention, and Access to Care. Arlington, VA, US.
- 2008. 11th Annual Association of Physician Assistants in Oncology (APAO) Conference, 9-10am, Infectious Diseases in the Oncology Patient. Conference. 11th Annual Association of Physician Assistants in Oncology (APAO) Conference, 9-10am, Infectious Diseases in the Oncology Patient. Denver, CO, US.
- 2006. PR002, Practitioner’s Report: Infectious Diseases, ACP Annual Session 2006. Conference. PR002, Practitioner’s Report: Infectious Diseases, ACP Annual Session 2006. Philadelphia, PA, US.
- 2006. Faculty Presenter, PR001, Practitioner’s Report: Infectious Diseases, ACP Annual Session 2006, Philadelphia, PA, April 6, 2006. Master Clinician: Richard P. Wenzel, MD, MSc, MACP. Conference. Faculty Presenter, PR001, Practitioner’s Report: Infectious Diseases, ACP Annual Session 2006, Philadelphia, PA, April 6, 2006. Master Clinician: Richard P. Wenzel, MD, MSc, MACP. Philadelphia, PA, US.
International Presentations
- 2019. "Cutpoints: Definition, Methods, and Review" at PROs in the Clinical Setting. Conference. "Cutpoints: Definition, Methods, and Review" at PROs in the Clinical Setting. Houston, US.
Formal Peers
- 2023. ID Grand Rounds-Diagnostic Stewardship. Invited. Columbia, MO, US.
- 2022. REDE to Communicate® Model of Healthcare Communication. Houston, Texas, US.
- 2018. Cancer and HIV. Invited. Galveston, TX, US.
- 2013. HIV Screening in Cancer Patients. Invited. Galveston, TX, US.
- 2012. HIV and Malignancy: Testing at a Cancer Center. Invited. Houston, TX, US.
- 2005. An Approach to Improve Hospital Influenza Immunization Rates. Invited. Iowa City, IA, US.
Grant & Contract Support
| Date: | 2005 - 2006 |
| Title: | AIDS Clinical Trials Unit, The University of Texas Medical Branch |
| Funding Source: | UTMB |
| Role: | Sub Investigator |
| Date: | 2005 - 2006 |
| Title: | A Randomized Double Blind Placebo Controlled Phase II Study to Assess the Safety and Efficacy of the Cytomegalovirus gB/MF59 Vaccine in Preventing Systemic Cytomegalovirus Infection in Healthy Adolescent Females |
| Funding Source: | NIH/DMID |
| Role: | Institutional Safety Monitor |
| Date: | 2002 - 2003 |
| Title: | T32 Emerging and Re-emerging Infectious Diseases, Study of Molecular Determinants of Virulence of West Nile Virus Infection, WHO Collaborating Center for Tropical Diseases, Sealy Center for Vaccine Development |
| Funding Source: | NIH/NIAID |
| Role: | Postdoctoral Fellow |
Selected Publications
Peer-Reviewed Articles
- Torres, HA, Mustafayev, K, Juneau, RP, Hwang, JP, Wang, LS, Angelidakis, G, Hawk, E, Granwehr, BP, Yepez Guevara, E, Ying, AK. Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. JNCCN Journal of the National Comprehensive Cancer Network 22(2D), 2024. e-Pub 2024. PMID: 38729204.
- . False-Reactive Fourth-Generation Human Immunodeficiency Virus Testing in Cancer Patients. Clinical Infectious Diseases 78(3):674-680, 2024. e-Pub 2024. PMID: 37930789.
- Noh, S, Bertini, CD, Mira-Avendano, I, Kaous, M, Patel, B, Faiz, S, Shannon, VR, Balachandran, D, Bashoura, L, Adachi, R, Evans, S, Dickey, BF, Wu, CC, Shroff, G, Manzano, JM, Granwehr, BP, Holloway, S, Dickson, KB, Mohammed, AD, Muthu, M, Song, H, Aroe, A, Aloia, TA, Lee Andrews, II, Badami, KK, Beird, H, Brock, K, Cata, JP, Dabaja, BS, Draetta, G, French, KE, Godoy, M, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Musunuru, TN, Nates, JL, Palaskas, NL, Ravi, V, Scheet, PA, Shete, S, Subbiah, IM, Tawbi, H, Woodman, SE, Chung, C, Khawaja, F, Sheshadri, A. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer. Cancer medicine 12(17):17753-17765, 2023. e-Pub 2023. PMID: 37592894.
- Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Guevara EY, Granwehr BP, Kaseb A, Naing A, Patel S, Shah AY, Skoulidis F, Tawbi HA, Wang L, Miller E, Zhang HC, Zurita-Saavedra A, Torres HA. Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients with Solid Tumors. Am J Gastroenterol 118(9):1609-1617, 2023. e-Pub 2023. PMID: 37307533.
- Nardo M, Yilmaz B, Nelson BE, Torres HA, Wang LS, Granwehr BP, Song J, Dalla Pria HRF, Trinh VA, Glitza Oliva IC, Patel SP, Tannir NM, Kaseb AO, Altan M, Lee SS, Miller E, Zhang H, Stephen BA, Naing A. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience. Oncologist 28(8):714-721, 2023. e-Pub 2023. PMID: 36952233.
- Williams LA, Whisenant MS, Mendoza TR, Peek AE, Malveaux D, Griffin DK, Ponce DA, Granwehr BP, Sheshadri A, Hutcheson KA, Ali SM, Peterson SK, Heymach JV, Cleeland CS, Subbiah IM. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes 7(1):48, 2023. e-Pub 2023. PMID: 37237077.
- Dagher H, Chaftari AM, Subbiah IM, Malek AE, Jiang Y, Lamie P, Granwehr B, John T, Yepez E, Borjan J, Reyes-Gibby C, Flores M, Khawaja F, Pande M, Ali N, Rojo R, Karp DD, Chaftari P, Hachem R, Raad II. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife 12, 2023. e-Pub 2023. PMID: 36748905.
- Fabre V, Davis A, Diekema DJ, Granwehr B, Hayden MK, Lowe CF, Pfeiffer CD, Sick-Samuels AC, Sullivan KV, Van Schooneveld TC, Morgan DJ. Principles of diagnostic stewardship: A practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force. Infect Control Hosp Epidemiol 44(2):178-185, 2023. e-Pub 2023. PMID: 36786646.
- Raad II, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Fernández Cruz A, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragovich T, Vong Kiat YE, Fakhreddine S, Pierre AH, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Yepez EY, Torres HA, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García AG, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, (D3CODE) Team DDFCODE, Kontoyiannis DP, Malek AE, Chaftari AM. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife 12, 2023. e-Pub 2023. PMID: 36715684.
- Yibirin M, Hosry J, Yepez Guevara E, Granwehr BP, Jiang Y, Mustafayev K, Angelidakis G, Torres HA. High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus. Eur J Gastroenterol Hepatol 34(10):1098-1101, 2022. e-Pub 2022. PMID: 36062500.
- Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Á G, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, (D3CODE) Team DDFCODE, Kontoyiannis DP, Malek AE, Chaftari AM. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv, 2022. e-Pub 2022. PMID: 36097568.
- Granwehr BP, Merriman KW, Chiao EY, Grimes RM. Cancer Patient Acceptance of HIV Screening at a Large Tertiary Cancer Center. JNCI Cancer Spectr 9(6):pkac055, 2022. e-Pub 2022. PMID: 35944228.
- Desai AN, Ruidera D, Steinbrink JM, Granwehr B, Lee DH. Misinformation and Disinformation: The Potential Disadvantages of Social Media in Infectious Disease and How to Combat Them. Clin Infect Dis 74(Suppl_3):e34-e39, 2022. e-Pub 2022. PMID: 35568471.
- Pundhir P, Roach LR, Bartek JR, Trask RP, Yibirin M, Guevara EY, Granwehr BP, Swalwell CR, Torres HA. Nursing practice is associated with high risk for hepatitis C virus infection. Clin Microbiol Infect 27(9):1362-1364, 2021. e-Pub 2021. PMID: 33984487.
- Marcelin JR, Cortés-Penfield N, Del Rio C, Desai A, Echenique I, Granwehr B, Lawal F, Kuriakose K, Lee DH, Malinis M, Ruidera D, Siddiqui J, Spec A, Swartz TH. How the Field of Infectious Diseases Can Leverage Digital Strategy and Social Media Use During a Pandemic. Open Forum Infect Dis 8(2):ofab027, 2021. e-Pub 2021. PMID: 33634204.
- Malek AE, Granwehr BP. Doxycycline as an Alternative to Azithromycin in Elderly Patients. Int J Antimicrob Agents 57(1):106168, 2021. e-Pub 2021. PMID: 33408018.
- Bajaj N, Granwehr BP, Hanna EY, Chambers MS. Salivary detection of SARS-CoV-2 (COVID-19) and implications for oral health-care providers. Head Neck 42(7):1543-1547, 2020. e-Pub 2020. PMID: 32533621.
- Sam A, George J, Taylor J, Hwang J, Chisholm G, Granwehr B, Soliman P, Schmeler K. Improving the Prevalence of HIV Testing Among Patients in a Gynecologic Oncology Department: Results of a Quality Improvement Project. JCO Oncol Pract 16(1):JOP1900382, 2020. e-Pub 2020. PMID: 31730416.
- Malek AE, Granwehr BP, Kontoyiannis DP. Doxycycline as a potential partner of COVID-19 therapies. IDCases 21:e00864, 2020. e-Pub 2020. PMID: 32566483.
- Torres HA, Economides MP, Angelidakis G, Hosry J, Kyvernitakis A, Mahale P, Jiang Y, Miller E, Blechacz B, Naing A, Samaniego F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-Based Therapy in Hepatitis C Virus-infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol 114(2):250-257, 2019. e-Pub 2019. PMID: 30410039.
- Rice TW, Brock PA, Gonzalez C, Merriman KW, Shelal Z, Bazerbashi H, Granwehr BP. Routine HIV Screening in Cancer Patients in the Emergency Department. Acute Med 17(2):91-95, 2018. e-Pub 2018. PMID: 29882559.
- Angelidakis G, Hwang JP, Dandachi D, Economides MP, Hosry J, Granwehr BP, Torres HA. Universal screening for hepatitis C: A needed approach in patients with haematologic malignancies. J Viral Hepat 25(9):1102-1104, 2018. e-Pub 2018. PMID: 29660201.
- Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller E, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study. J Clin Oncol 36(10):JCO2017756387, 2018. e-Pub 2018. PMID: 29447061.
- Rice, TW, Brock, PA, Gonzalez, CE, Merriman, K, Shelal, Z, Bazerbashi, H, Granwehr, BP. Routine HIV Screening in Cancer Patients in the Emergency Department. Acute Medicine 17(2):91-95, 2018. e-Pub 2018.
- Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola GM, Amin S, Assaf A, Numan Y, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. Correction for Chaftari et al., "A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients". Antimicrob Agents Chemother 61(8), 2017. e-Pub 2017. PMID: 28743701.
- Ariza-Heredia EJ, Granwehr BP, Viola GM, Bhatti M, Kelley JM, Kochenderfer J, Hosing C. False-positive HIV nucleic acid amplification testing during CAR T-cell therapy. Diagn Microbiol Infect Dis 88(4):305-307, 2017. e-Pub 2017. PMID: 28610774.
- Tverdek FP, Heo ST, Aitken SL, Granwehr B, Kontoyiannis DP. Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses. Antimicrob Agents Chemother 61(8), 2017. e-Pub 2017. PMID: 28507111.
- Chaftari AM, Hachem R, Szvalb A, Taremi M, Granwehr B, Viola GM, Amin S, Assaf A, Numan Y, Shah P, Gasitashvili K, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother 61(7), 2017. e-Pub 2017. PMID: 28416559.
- Economides MP, Mahale P, Turturro F, Hosry J, Samaniego F, Granwehr BP, Torres HA. Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy. Leuk Lymphoma 27(2):1-4, 2017. e-Pub 2017. PMID: 27348218.
- Hosry J, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Antiviral therapy improves survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. Int J Cancer 139(11):2519-28, 2016. e-Pub 2016. PMID: 27501007.
- Torres HA, Roach LR, Mahale P, Economides MP, Blechacz B, Miller E, Borchardt R, Rashid A, Oo TH, Shukla B, Farida M, Ericsson CD, Granwehr BP, Raad II. Transdisciplinary approach to managing Hepatitis C virus infection in patients at tertiary care cancer center. J Natl Compr Canc Netw 14(9):1185-8, 2016. e-Pub 2016. PMID: 27587628.
- Chaftari AM, Hachem R, Jordan M, Garoge K, Al Hamal Z, El Zakhem A, Viola GM, Granwehr B, Mulanovich V, Gagel A, Reitzel R, Yousif A, Jiang Y, Raad I. Case-control study of Telavancin as an alternative treatment for gram-positive bloodstream infections in patients with cancer. Antimicrob Agents Chemother 19(60):239-44, 2016. e-Pub 2016. PMID: 26482312.
- Hwang JP, Granwehr BP, Torres HA, Suarez-Almazor ME, Giordano TP, Barbo AG, Lin HY, Fisch MJ, Chiao EY. HIV testing in patients with cancer at the initiation of therapy at a large US comprehensive cancer center. J Oncol Pract 11(5):384-90, 2015. e-Pub 2015. PMID: 26243649.
- Neofytos D, Railkar R, Mullane KM, Fredricks DN, Granwehr B, Marr KA, Almyroudis NG, Kontoyiannis DP, Maertens J, Fox R, Douglas C, Iannone R, Kauh E, Shire N. Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis. PLoS One 10(6):e0129022, 2015. e-Pub 2015. PMID: 26107507.
- Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola GM, Ariza-Heredia E, Adachi JA, Chemaly RF, Marfatia R, Jiang Y, Mahale P, Kyvernitakis A, Fanale MA, Mulanovich V. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect 20(10):672-9, 2014. e-Pub 2014. PMID: 24529214.
- Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II. A multicenter study of pandemic influenza a (H1N1) infection in patients with solid tumors in 3 countries: Early therapy improves outcomes. Cancer 118(18):4627-33, 2012. e-Pub 2012. PMID: 22359314.
- Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF. Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis J 31(4):373-8, 2012. e-Pub 2012. PMID: 22228234.
- Cairo J, Hachem R, Rangaraj G, Granwehr B, Raad I. Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients. Clin Microbiol Infect 17(11):1711-16, 2011. e-Pub 2011. PMID: 21595787.
- Al Wohoush I, Cairo J, Rangaraj G, Granwehr B, Hachem R, Raad I. Comparing quantitative culture of a blood sample obtained through the catheter with differential time to positivity in establishing a diagnosis of catheter-related bloodstream infection. Infect Control Hosp Epidemiol 31(10):1089-91, 2010. e-Pub 2010. PMID: 20807036.
- Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 116(4):967-73, 2010. e-Pub 2010. PMID: 20052728.
- Duarte AG, Sattar F, Granwehr B, Aronson JF, Wang Z, Lick S. Disseminated acanthamoebiasis after lung transplantation. J Heart Lung Transplant 25(2):237-40, 2006. e-Pub 2006. PMID: 16446227.
- Granwehr BP, Li L, Davis CT, Beasley DW, Barrett AD. Characterization of a West Nile Virus Isolate from a Human on the Gulf Coast of Texas. J Clin Microbiol 42(11):5375-5377, 2004. e-Pub 2004. PMID: 15528747.
- Granwehr BP, Lillibridge KM, Higgs S, Mason PW, Aronson JF, Campbell GA, Barrett AD. West Nile Virus: Where Are We Now?. Lancet Infect Dis 4(9):547-56, 2004. e-Pub 2004. PMID: 15336221.
- Beasley DWC, Davis CT, Whiteman M, Granwehr B, Kinney RM and Barrett ADT. Molecular determinants of virulence of West Nile virus in North America. In "Emergence and control of zoonotic viral encephalitides" Edited by CH Calisher and DE Griffin. Archives of Virology 18:35-41, 2004. e-Pub 2004.
- Solomon T, Fisher AF, Beasley DW, Mandava P, Granwehr BP, Langsjoen H, Travassos Da Rosa AP, Barrett AD, Tesh RB. Natural and Nosocomial Infection in a Patient with West Nile Encephalitis and Extrapyramidal Movement Disorders. Clin Infect Dis 36(11):e140-145, 2003. e-Pub 2003. PMID: 12766856.
- Merrill DC, Granwehr BP, Davis DR, and Sigmund CD. Use of Transgenic and Gene-Targeted Mice to Model the Genetic Basis of Hypertensive Disorders. Proc Assoc Am Physicians 109(6):533-546, 1997. e-Pub 1997. PMID: 9394415.
- Merrill DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robillard JE, Sigmund CD. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97(4):1047-55, 1996. e-Pub 1996. PMID: 8613528.
- Merrill, DC, Carney, CL, Granwehr, BP, Schlager, G, Robillard, JE, Sigmund, CD. Cardiovascular control in conscious transgenic mice carrying human renin and human angiotensinogen genes. FASEB Journal 10(3):A21, 1996. e-Pub 1996.
Invited Articles
- Granwehr BP. In adults who had not had COVID-19, Novavax vaccine had 90% efficacy at =7 d after the second dose. Ann Intern Med 175(5):JC52, 2022. e-Pub 2022. PMID: 35500261.
- Granwehr BP. BioNTech/Pfizer vaccine after Oxford/AZ vaccine increased immune response vs. no second vaccine. Ann Intern Med 174(11):JC123, 2021. e-Pub 2021. PMID: 34724407.
- Granwehr BP. In acute uncomplicated influenza, single-dose baloxavir decreased time to symptom relief compared with placebo. Ann Intern Med 169(12):JC63, 2018. e-Pub 2018. PMID: 30557416.
- Granwehr B, Kontoyiannis DP. The evolving landscape of gastrointestinal infections in neutropenic patients. Oncology (Williston Park) 29(8):592-3, 2015. e-Pub 2015. PMID: 26349340.
- Granwehr B. ACP Journal Club: quadrivalent HPV vaccination was not linked to multiple sclerosis or other demyelinating diseases. Ann Intern Med 162(8):JC13, 2015. e-Pub 2015. PMID: 25894046.
- Granwehr B. Review: Influenza vaccine reduces influenza-like illness in healthy adults. Ann Intern Med 161(6):JC6, 2014. e-Pub 2014. PMID: 25222418.
- Granwehr B. ACP Journal Club. Review: Influenza vaccination reduces cardiovascular events in adults. Ann Intern Med 160(4):JC2, 2014. e-Pub 2014. PMID: 24534936.
- Granwehr B. Journal Club. Commentary. Review: Influenza vaccination reduces cardiovascular events in adults. Ann Intern Med 160(4):JC2, 2014. e-Pub 2014.
- Granwehr B. ACP Journal Club. A 15-microg dose of unadjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in healthy adults within 21 days. Ann Intern Med 152(2):JC1-9, JC1-8, 2010. e-Pub 2010. PMID: 20083824.
- Granwehr B. ACP Journal Club. One or two 7.5-microg doses of MF59-adjuvanted influenza A (H1N1) 2009 vaccine was immunogenic in adults within 21 days. Ann Intern Med 152(2):JC1-8, JC1-9, 2010. e-Pub 2010. PMID: 20083823.
- Granwehr BP. ACP Journal Club. Quadrivalent HPV vaccine reduced risk for HPV infection and related disease in women 24 to 45 years of age. Ann Intern Med 151(8):JC4-12, 2009. e-Pub 2009. PMID: 19841449.
- Granwehr BP. Influenza immunization during pregnancy reduced influenza in infants and respiratory illness in mothers. Evid Based Med 14(2):55, 2009. e-Pub 2009. PMID: 19332611.
- Granwehr BP. ACP Journal Club. Influenza immunization during pregnancy reduced influenza in infants and respiratory illness in mothers. Ann Intern Med 150(4):JC2-5, 2009. e-Pub 2009. PMID: 19238603.
- Granwehr B. Inactivated influenza vaccine prevented influenza in healthy adults. ACP J Club 146(3):60, 2007. e-Pub 2007. PMID: 17474669.
Review Articles
- Abu Khalaf S, Dandachi D, Granwehr BP, Rodriguez-Barradas MC. Cancer Immunotherapy in Adult Patients with HIV. J Investig Med 70(4):883-891, 2022. e-Pub 2022. PMID: 35086858.
- Granwehr BP, Kontoyiannis DP. The Impact of Infectious Diseases Consultation of Oncology Practice. Curr Opin Oncol 4(4):353-9, 2013. e-Pub 2013. PMID: 23736876.
- Beasley, DW, Davis, CT, Whiteman, M, Granwehr, BP, Kinney, RM, Barrett, AD. Molecular determinants of virulence of West Nile virus in North America. Archives of virology. Supplementum(18):35-41, 2004. e-Pub 2004. PMID: 15119761.
Professional Educational Materials
- Granwehr, B, Hashmey R. Disseminated Histoplasmosis (Including Cutaneous, Bone Marrow, and Pulmonary Involvement) in an HIV Positive Patient with a CD4 Count of 505. Partners Infectious Diseases Images Website, 2003.
Other Articles
- Granwehr, BP CBT and rehabilitation improved long COVID symptoms. Annals of internal medicine 178(3):JC28, 2025. PMID: 40030181.
- Granwehr, BP In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d. Annals of internal medicine 177(6):JC67, 2024. PMID: 38830218.
- Granwehr, BP In women with uncomplicated UTIs, gepotidacin was noninferior to nitrofurantoin for therapeutic response at 10 to 13 d. Annals of internal medicine 177(6):JC66-JC67, 2024. PMID: 38830223.
- Granwehr, BP In mild to moderate COVID-19, VV116 safely reduced time to sustained clinical symptom resolution. Annals of internal medicine 177(3):JC35, 2024. PMID: 38437701.
Abstracts
- Hachem, RY, Chaftari, AM, Masayuki, N, al E. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome. Open Forum Infectious Diseases 8(Supplement 1):S15, 2021. e-Pub 2021.
- Dagher, H, Malek, A, al E. Long COVID in Cancer Patients: Preponderance of Symptoms in Majority of Patients over Long Time Period. Open Forum Infectious Diseases 8(Supplement 1):S257, 2021. e-Pub 2021.
- Subbiah, IM, Mendoza, TR, al E. Implementation of a Novel Patient-Reported Outcomes Measure for Patients with Cancer and COVID-19 Infection. Journal of Clinical Oncology 39(Supplement 28):153, 2021. e-Pub 2021.
- Subbiah, IM, Williams, LA, al E. Real-world Patient-Reported and Clinical Outcomes of BNT162b2 mRNA COVID-19 Vaccine in Patients with Cancer. Journal of Clinical Oncology 39(Supplement 15):6510, 2021. e-Pub 2021.
- Pundhir P, Angelidakis G, Naing A, Granwehr BP, Torres HA. Hepatitis C Virus Infection is a Major Exclusion Criterion for Oncology Clinical Trials: A Call to Revisit Eligibility Criteria in the Era of Direct-Acting Antivirals. The Liver Meeting 2018, San Francisco, CA, 2018. e-Pub 2018.
- Hosry J, Angelidakis G, Granwehr B, Torres HA. Short-duration of Direct-acting Antivirals in Hepatitis C Virus Infected Cancer Patients. IDWeek, San Francisco, CA, 2018. e-Pub 2018.
- Torres HA, Economides MP, Kyvernitakis A, Mahale P, Hosry J, Jiang Y, Turturro F, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-based therapy in patients with chronic Hepatitis C virus infection and malignancies - A prospective observational study of 143 patients. The 53rd Annual Mtg of Amer Society of Clinical Oncol (ASCO), Chicago, IL, 2017. e-Pub 2017.
- Torres HA, Economides MP, Kyvernitakis A, Mahale P, Hosry J, Jiang Y, Kaseb A, Raad II, Granwehr BP. Sofosbuvir-based therapy in patients with chronic Hepatitis C virus infection and malignancies - A prospective observational study of 136 patients. The International Liver Congress, Amsterdam, Netherlands, 2017. e-Pub 2017.
- Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr B, Miller E, Suarez-Almazor ME. Predicting Hepatitis B virus infection among patients with cancer undergoing systemic anti-cancer therapy: A prospective cohort study. Society of Gen Intern Med (SGIM), Washington, DC, 2017. e-Pub 2017.
- Economides MP, Mahale P, Hosry J, Jiang Y, Granwehr BP, Torres HA. Sofosbuvir-based therapy in patients with chronic Hepatitis C virus infection and malignancies - A prospective observational study of 60 patients. ID Week, New Orleans, LA, 2016. e-Pub 2016.
- Aitken SL, Heo ST, Tverdek FP, Granwehr BP, Kontoyiannis DP. Effectiveness and safety of new posaconazole formulations in patients with hematologic malignancy receiving antifungal prophylaxis. ID Week, New Orleans, LA, 2016. e-Pub 2016.
- Chaftari A, Hachem R, Szvalb AD, Taremi M, Granwehr B, Viola GM, Sapna A, Assaf A, Numan Y, Shah P, Felix E, Natividad E, Jiang Y, Slack R, Reitzel R, Rosenblatt J, Mouhayar E, Raad I. A novel non-antibiotic nitroglycerin based catheter lock solution for the prevention of intraluminal central venous catheter related blood stream infections (CRBS) in cancer patients. ID Week, New Orleans, LA, 2016. e-Pub 2016.
- j H, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Effect of Antiviral Therapy on Overall Survival Rate in Hepatitis C Virus-Infected Patients with Diffuse Large B-Cell Lymphoma. 52nd Annual Meeting of American Society of Clinical Oncology (ASCO), Chicago, IL, Winner of 2016 Conquer Cancer Foundation of ASCO Merit Award, 2016. e-Pub 2016.
- Economides MP, Mahale P, Turturro F, Hosry J, Granwehr BP, Torres HA. Development of Non-Hodgkin's Lymphoma as a Second Primary Cancer in Hepatitis C Virus-Infected Patients. 52nd Annual Meeting of American Society of Clinical Oncology (ASCO), Chicago, IL, 2016. e-Pub 2016.
- Tverdek FP, Heo ST, Aitken SL, Granwehr B, Kontoyiannis DP. Real-world use of posaconazole delayed release tablets in patients with hematologic malignancy. Oral Presentation. Amer Society of Microb (ASM ) Microbe, Boston, MA, 2016. e-Pub 2016.
- Granwehr BP, Merriman KW, Routbort M, Grimes R. HIV Testing in a Cancer Center. International Symposium HIV and Emerging Infectious Diseases (ISHEID), Marseille, France, 2016. e-Pub 2016.
- Granwehr BP, Merriman KW, Grimes R, Shelal Z, Bazerbashi H, Brock PA, Gonzalez CE, Torres HA, Rice TW. HIV, HBV, HCV Screening in a Cencer Center Emergency Department. International Symposium HIV and Emerging Infectious Diseases (ISHEID), Marseille, France, 2016. e-Pub 2016.
- Granwehr BP, Merriman KW, Shelal Z, Bazerbashi H, Brock PA, Gonzalez CE, Torres HA. HIV Testing in a Cancer Center Emergency Department. American Society of Clinical Oncolgy (ASCO) Quality Symposium, Phoeniz, AZ, 2016. e-Pub 2016.
- Granwehr BP, al E. Screening for HIV in the Emergency Department of a comprehensive cancer center: Recommendations and challenges. 2015 National Summit on HCV and HIV diagnosis, Poster Presentation, Arlington, VA, 2015. e-Pub 2015.
- Hwang JP, Granwehr BP, al E. HIV testing among patients with cancer before initiation of chemotherapy. Society of General Internal Medicine 38th Annual Meeting, Scientific Abstract Poster Session, Toronto, ON, Canada, 2015. e-Pub 2015.
- Torres HA, Roach L, Mahale P, Granwehr B, al E. Transdisciplinary approach to managing hepatitis C virus infection in patients at a tertiary cancer center. Poster Presentation, ID Week, San Diego, CA, 2015. e-Pub 2015.
- Granwehr BP, al E. Opt-out testing for HIV in the Emergency Room of a comprehensive cancer center. Poster Presentation at MASCC/ISOO Annual Meeting on Supportive Care in Cancer, Copenhagen, Denmark, 2015. e-Pub 2015.
- Granwehr BP, al E. Current state of HIV testing in a comprehensive cancer center. 2015 National Summit on HCV and HIV Diagnosis, Poster Presentation, Arlington, VA, 2015. e-Pub 2015.
- Granwehr BP, Merriman K, Grimes R, Torres H, Mulanovich V, Routbort M, Chiao, E. HIV testing in a cancer center. ID Week 2013, San Francisco, CA, USA, 2013. e-Pub 2013.
- Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola G, Ariza-Heredia E, Chemaly RF, Jiang Y, Marfatia R, Shelburne S, Mulanovich V. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Abstracts and Poster Walk at 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Denver, CO, USA, 2013. e-Pub 2013.
- Neofytos D, Mullane, K, Fredricks D, Granwehr B, Marr K, Almyroudis N, Kontoyiannis D, Maertens J, Fox R, Douglas C, Iannone R, Kauh A, Railkar R, Shire N. Correlation Between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis. Abstract M-1676. 52nd Annual Meeting Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, 2012. e-Pub 2012.
- Torres HA, Davila M, Mulanovich V, Granwehr BP, Miller E, Nevah MI, Mishra L, Kontoyiannis DP, Raad II. Hepatitis C Clinic at a comprehesive cancer center: The successful story of multidisciplinary efforts. 49th Annual Meeting of the Infectious Diseases Society of America, 2011. e-Pub 2011.
- Torres H, Mahale P, Davila M, Mulanovich VE, Granwehr B, Kontoyiannis D, Raad I. Hepatitis C virus infection in cancer patients: The story of a forgotten population. Abstract 729. 48th Annual Meeting Infectious Diseases Society of America, Vancouver, Canada, October 21-23, 2010. e-Pub 2010.
- Vigil K, Adachi J, Jiang Y, Popat U, Mahani MG, Granwehr B, Malik I, Gaeta S, Champlin RE, Raad I, Chemaly R. Novel influenza A (2009/H1N1) infection in cancer patients during the ongoing pandemic: Early therapy improves outcome. Abstract 762. 48th Annual Meeting Infectious Diseases Society of America, Vancouver, Canada, October 21-23, 2010. e-Pub 2010.
- Torres HA, Davila M, Mulanovich VE, Granwehr BP, Miller E, Nevah MI, Mishra L, Kontoyiannis D, Raad I. Hepatitis C clinic at a comprehensive cancer center: The successful story of multidisciplinary efforts. Abstract 1291. 48th Annual Meeting Infectious Diseases Society of America, Vancouver, Canada, October 21-23, 2010. e-Pub 2010.
- Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Raad II, Chemaly RF. Influenza virus infections in pediatric cancer patients - emphasis on preemptive therapy. Abstract 1098. 47th Annual Meeting Infectious Diseases Society of America, Philadelphia, PA, October 29-November 1, 2009. e-Pub 2009.
- Shah JN, Vigil KJ, Rathod DB, Mihu CN, Granwehr BP, Raad II, Chemaly RF. Respiratory syncytial virus infection in children with cancer - To treat or not to treat? Abstract 606. 47th Annual Meeting Infectious Diseases Society of America, Philadelphia, PA, October 29 - November 1, 2009. e-Pub 2009.
- Cairo J, Rangaraj G, Hachem R, Granwehr B, Raad I. Predictors of catheter related gram negative bacteremia (CR-GNB) in cancer patients. Abstract 444. 47th Annual Meeting Infectious Diseases Society of America, Philadelphia, PA, October 29 - November 1, 2009. e-Pub 2009.
- Cairo J, Rangaraj G, Chaftari A, Granwehr B, Hachem R, Raad II. Is a single quantitative blood culture (QBC) collected through the central venous catheter (CVC) diagnostic of catheter-related bloodstream infections (CRBSIs)? Abstract 230. 47th Annual Meeting Infectious Diseases Society of America, Philadelphia, PA, October 29 - November 1, 2009. e-Pub 2009.
- Rangaraj G, Granwehr B, Hachem R, Jiang Y, Raad II. Fluoroquinolone prophylaxis and the risk of breakthrough bacteremia caused by multi-drug resistant (MDR) organisms in cancer patients (C2-3879). 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, October 23-28, 2008. e-Pub 2008.
- Chemaly RF, Tarrand J, Adachi J, Nguyen K, Su J, Awosika-Olumo D, Short K, Pascoe N, Blossom D, Srinivasan A, Graviss L, Mulanovich V, Granwehr B, Rolston K, and Raad II. Investigation of an Outbreak of Serratia marcescens Bacteremia in Cancer Patients Leading to a National Recall of a Second Unsuspected Contaminated Source: Time for Antimicrobial Lock Therapy. Oral Presentation at The 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, October 25-28, 2008. e-Pub 2008.
- Granwehr BP, Falk PS, Zhang L, Mayhall CG, and Myers MG. Impact of a Computerized Physician Order Entry (CPOE) System-Based Prompt on Inpatient Influenza Vaccination Rates. 43rd Annual Meeting of the Infectious Diseases Society of America, San Francisco, California, 2005. e-Pub 2005.
- Granwehr BP, Freeman DH, Turley CB, Stanberry LR, and Myers MG. Galveston Immunization Survey. Presented at Poster Session, The Changing Landscape of Vaccine Development: Translating Vaccines for Emerging Infectious Diseases and Biodefense to the Marketplace. Galveston, Texas, 2004. e-Pub 2004.
- Beasley, DWC, Davis, CT, Whiteman, M, Granwehr, B, Kinney, RM, Barrett, ADT. Molecular Determinants of West Nile virus in America. International Symposium on Emerging Zoonotic Viral Encephalitis, Annecy, France, 2003. e-Pub 2003.
- Granwehr, BP, Li, L, Davis, CT, Beasley, DW, Barrett A, AD. Evolution of West Nile Virus in the United States: Genetic Characterization of a Human Isolate from Beaumont, Texas. 41st Annual Meeting of the Infectious Disease Society of America, San Diego, California, 2003. e-Pub 2003.
- Granwehr BP, Hashmey RH. Bilateral Thalamic Lesions in a West Nile Virus Encephalitis Patient on Immunosuppression after Renal Transplant. 51st Annual Meeting of the American Society of Tropical Medicine and Hygiene, Denver, CO, 2002. e-Pub 2002.
- Granwehr, B, Shaw-Stiffel, T. Clinical Vignette: A Fatal Case of Sickle Cell Intrahepatic Cholestasis. Can J Gastroenterol 16 (Suppl.)(90A), 2002. e-Pub 2002.
- Granwehr BP, Peterson EK. A Fatal Case of Nontropical Pyomyositis. Clinical Vignette Competition at the 80th Annual Session of the ACP-ASIM (American College of Physicians-American Society of Internal Medicine), New Orleans, LA, 1999. e-Pub 1999.
- Manning SM, Granwehr BP, Bernfield M. Fine mapping and candidate gene analysis of the CT mouse model of neural tube defects (NTD): an approach to identify human NTD genes. Society for Pediatric Research/American Pediatric Society National Meeting, 1997. e-Pub 1997.
- Merrill D, Smith S, Granwehr B, Carney C, Sigmund C. Human renin gene expression during pregnancy in transgenic mice. Society of Gynecologic Investigation (SGI), Philadelphia, Pennsylvania, 1996. e-Pub 1996.
Book Chapters
- Granwehr, B, Kontoyiannis, DP. Fungal Infections in Cancer Patients. In: The MD Anderson Manual of Medical Oncology. 4. McGraw Hill, 1363-1380, 2022.
- Granwehr BG, Epner DE. Tell Me Stories. In: Empathy: Real Stories to Inspire and Enlighten Busy Clinicians. McGraw Hill, 97-107, 2022.
- Granwehr, BP, Kontoyiannis, DP. Fungal infections in Cancer Patients. In: Encyclopedia of Mycology. 1st. Elsevier, 792-802, 2021.
- Granwehr, BP, Kontoyiannis, DP. Fungal Infections in Cancer Patients, V1-792-V1-802, 2021.
- Granwehr, BP, Sipsas, NV, Kontoyiannis, DP. Fungal infections in cancer patients, 1337-1360, 2019.
- Granwehr BP, Sipsas NV, Kontoyiannis DP. Fungal Infections in Cancer Patients. In: Oncologic Critical Care. 1st. Springer Nature Switzerland, 1-24, 2019.
- Granwehr BP, Chemaly RF, Kontoyiannis DP. Fungal and Viral Infections in Cancer Patients. In: The MD Anderson Manual of Medical Oncology. 3rd. McGraw-Hill Companies, 1035-1055, 2016.
- Granwehr BP, Chemaly RF, Kontoyiannis DP. Fungal and Viral Infections in Cancer Patients. In: The MD Anderson Manual of Medical Oncology. 2nd. McGraw-Hill Companies, 1205-35, 2011.
- Safdar A, Granwehr BP, Harold SA, Dupont HL. Chapter 16: Neutropenic Enterocolitis and Clostridium difficile Infections. In: Management of Infections in Cancer Patients. Humana Press, 181-188, 2011.
- Watts, DM, Granwehr, BP, Shope, RE, Solomon, T, Tesh, RB. Japanese Encephalitis and West Nile and Other Flavivirus Infections, 823-830, 2006.
- Watts DM, Granwehr BP, Shope RE, Solomon TS, Tesh RB. Japanese Encephalitis and West Nile and Other Flavivirus Infections. In: Tropical Infectious Diseases. 2nd. Elsevier Publishers, 823-830, 2005.
Patient Reviews
CV information above last modified July 22, 2026